0001437749-20-021256.txt : 20201118 0001437749-20-021256.hdr.sgml : 20201118 20201019090422 ACCESSION NUMBER: 0001437749-20-021256 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 CORRESP 1 filename1.htm bcda20201016_corresp.htm

 

October 19, 2020

 

 

Via EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549-3720

 

Attention:      Abby Adams

 

Re:

BioCardia, Inc.
  Registration Statement on Form S-3
  Filed on October 9, 2020
  File No. 333-249426

 

 

Acceleration Request
Requested Date:
Requested Time:

October 20, 2020

5:00 P.M. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-249426) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company or its counsel may request via telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Nathan Robinson at (512) 338-5407 or via email at nrobinson@wsgr.com.

 

[Signature page follows.]

 

 
 

 

  Sincerely,  
     

 

BIOCARDIA, INC. 

 

 

 

 

 

 

 

 

 

 

By:

/s/ David McClung

 

 

 

David McClung 

 

 

 

Chief Financial Officer 

 

 

 

 

cc:

Nathan Robinson, Esq.



Wilson Sonsini Goodrich & Rosati, Professional Corporation